For Patients Undergoing Brain Tumor Surgery, Low T3 Syndrome Found to be Biomarker of Poor Outcome-Clinical Implications Remain Unclear
Oncology Times - Jul 10, 2013
Also asked for his opinion, David M. Peereboom, MD, FACP, a staff physician in the Department of Solid Tumor Oncology at Cleveland Clinic Taussig Cancer Institute, said he doesn't see any immediate clinical implications: "I think that T3 syndrome is an epiphenomenon," he said. "We see it in patients who are ill, and we know they are going to continue to be ill. But it doesn't change what we do."
Soy Doesn't Prevent Prostate Cancer Return: Study
Reuters UK - Jul 9, 2013
Men who took soy supplements after having their prostate cancer removed were just as likely to see their cancer return as men who didn't take soy, in a new study..."This adds to the evidence that nutrition supplements really aren't beneficial," said Dr. Eric Klein, chairman of the Cleveland Clinic Glickman Urological and Kidney Institute.
Case Researchers Lead National Effort to Track Benefits of Genetic Testing in Cancer Treatment
ideastream - Jul 9, 2013
With the use of genetic testing in the cancer field on the rise, Cleveland's leading cancer experts want to make it easier for patients to have treatment that results from such tests covered. With the help of one lung cancer patient, Dr. Stan Gerson, who heads the Case Comprehensive Cancer Center at Case Western Reserve University and University Hospitals Seidman Cancer Center has a plan. Ideastream Health Reporter Sarah Jane Tribble explains.
American Cancer Society Institutional Research Grant (IRG) Awards
The Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
IRG pilot project grants are intended to support independent, self-directed investigators early in their careers (assistant professor or equivalent). Applicants for the pilot project grants should be within six years of their first independent research or faculty appointment and eligible to apply for an independent national competitive research grant, but cannot currently hold such a grant. Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.
LOI Deadline: August 12
Application Deadline: September 13
Awards and Lectureships presented at the AACR Annual Meeting
The American Association for Cancer Research (AACR) is accepting nominations for the following awards and lectureships that will be presented at the AACR Annual Meeting in April 2014:
OnCore Clinical Trials Management System Training Classes
April Firstencel, PRMC Manager and Registration Coordinator for Clinicaltrials.gov and NCI/CTRP, will host an OnCore Clinical Trials Management System Training Classes that will discuss Mandatory Fields in OnCore for NCI/CTRP and Clinicaltrials.gov registration and results reporting. This information is useful for regulatory, data managers and nursing.
The classes will be held on two different dates based on institution:
Please contact April Firstencel at email@example.com to register.
MSC 2013: Adult Stem Cell Therapy & Regenerative Medicine
Mark your calendars for MSC 2013: Adult Stem Cell Therapy & Regenerative Medicine, August 19-21, 2013 at Cleveland Marriott Downtown at Key Center. Presented by the National Center for Regenerative Medicine, this conference will offer a forum for the exchange and discussion of research, ideas, and cutting-edge breakthroughs in translational regenerative medicine. Online registration is open and poster abstracts are being accepted for presentation both in poster format and potentially accepted for platform presentation during the main program as well. Deadline is July 19 for poster abstract submission.
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Case CCC Funding for Pilot/Phase I Clinical Trials
PRCRP Career Development Award
American Gastroenterological Association Funderburg Research Award in Gastric Cancer
Case CCC Protocol Specific Research Support (PSRS)
International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
NIH BULLETIN – Notices and Funding Opportunities
Notice to Extend the 2013 Application Due Date and Provide Additional Instructions for Correct Application Package for PAR-13-126 "Limited Competition: Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43)" (NOT-TW-13-008)
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.
Special Presentation: Hematology and Oncology Research Conference
Rodrigo Calado, MD
Associate Professor, Internal Medicine
University of São Paulo
Topic: Telomeres and Hematologic Diseases
8 am SCC Learning Lab
Radiation Oncology Grand Rounds
Julio Cesar Marcassa, MD
International Atomic Energy Agency Visiting Scholar
Cancer Institute of São Paulo State
Topic: Radiation Oncology: USA vs. Brazil
12 pm Lerner Tower B-151
Hematology and Oncology Division Research Conference Fellowship Curriculum Series
Cheng Chee, MD
Assistant Professor, Hem/Onc
Topic: Introduction to Early Stage Colorectal Cancer
8 am Lerner Tower B-151
Cancer Biology Staff Candidate Seminar
James Brugarolas, MD, PhD
Assistant Professor, Internal Medicine and Developmental Biology
University of Texas Southwestern Medical Center
Topic: Emerging Targets and Future Directions in Renal Cancer
1 pm NA5-08 Cleveland Clinic
Cancer Center Research in Progress will resume in September
Taussig Cancer Institute Grand Rounds will resume in September
Hematology and Oncology Fellows Conference
8 am Wearn 137
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ADDITIONAL UPCOMING SEMINARS & EVENTS
National GvHD Health Symposium